92 related articles for article (PubMed ID: 4127705)
1. Anticoagulant treatment during abdominal surgery in a case of antithrombin 3 deficiency.
Egberg N; Thulin L
Acta Chir Scand; 1973; 139(6):577-8. PubMed ID: 4127705
[No Abstract] [Full Text] [Related]
2. Deficiency of antithrombin 3 activity associated with hereditary thrombosis tendency.
von Kaulla E; von Kaulla KN
J Med; 1972; 3(6):349-58. PubMed ID: 4520658
[No Abstract] [Full Text] [Related]
3. [The correction of disorders in the blood coagulating system during the surgical treatment of patients with pulmonary tuberculosis].
Priĭmak AA; Makinskiĭ AI; Ivan'ko TP; Makarova VV
Vrach Delo; 1991 Sep; (9):54-7. PubMed ID: 1759433
[No Abstract] [Full Text] [Related]
4. [Circulating heparinoid anticoagulant (antithrombin II). Report of a fatal case and review of the problem].
Goldstein C; Sumoza A; De Bosch N; De Sanz N
Sangre (Barc); 1973; 18(3):313-21. PubMed ID: 4757640
[No Abstract] [Full Text] [Related]
5. Abnormal bleeding during surgery.
Gans H
Arch Chir Neerl; 1971; 23(1):75-82. PubMed ID: 5579926
[No Abstract] [Full Text] [Related]
6. [Primary thrombophilia caused by antithrombin III deficiency].
Barkagan ZS; Bishevskiĭ KM; Sukhoveeva EIa
Ter Arkh; 1978; 50(8):101-6. PubMed ID: 694743
[No Abstract] [Full Text] [Related]
7. [Coagulation disorders in gynecology and obstetrics. 2. Pathologic coagulation and its treatment].
Vekemans M; Hendeles SM
J Gynecol Obstet Biol Reprod (Paris); 1974; 3(1):105-14. PubMed ID: 4143416
[No Abstract] [Full Text] [Related]
8. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations.
Tiede A; Tait RC; Shaffer DW; Baudo F; Boneu B; Dempfle CE; Horellou MH; Klamroth R; Lazarchick J; Mumford AD; Schulman S; Shiach C; Bonfiglio LJ; Frieling JT; Conard J; von Depka M
Thromb Haemost; 2008 Mar; 99(3):616-22. PubMed ID: 18327412
[TBL] [Abstract][Full Text] [Related]
9. Familial antithrombin III deficiency.
Br Med J; 1978 Feb; 1(6111):508. PubMed ID: 626859
[No Abstract] [Full Text] [Related]
10. [Hypercalcemia and antithrombin activity in a case of IgA myeloma].
Baele G; Lameire N
Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1444-50. PubMed ID: 5069831
[No Abstract] [Full Text] [Related]
11. [Chronic widespread intravascular coagulation syndrome and cyanotic congenital cardiopathy. The place of heparin during preoperative period].
Baille Y; Blanc T; Monties JR; Goudard A; Henry E
Presse Med (1893); 1970 Aug; 78(36):1571-4. PubMed ID: 5456287
[No Abstract] [Full Text] [Related]
12. [On preventive anticoagulant therapy in the surgical treatment of chronic arterial vascular occlusion].
Schlosser V
Thoraxchir Vask Chir; 1967 Apr; 15(2):152-5. PubMed ID: 4171714
[No Abstract] [Full Text] [Related]
13. The progressive antithrombin (antithrombin-III, heparin-cofactor).
Pálos LA
Haematologia (Budap); 1974; 8(1-4):455-9. PubMed ID: 4461431
[No Abstract] [Full Text] [Related]
14. [Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants].
Latallo ZS; Malanowicz W
Kardiol Pol; 1970; 13(4):351-8. PubMed ID: 4099312
[No Abstract] [Full Text] [Related]
15. [Cancer, hypercoagulability and thrombosis].
Sánchez Avalos JC
Sangre (Barc); 1971; 16(2):151-8. PubMed ID: 5314487
[No Abstract] [Full Text] [Related]
16. Anticoagulant treatment during and after embolectomy.
Holm J; Scherstén T
Acta Chir Scand; 1972; 138(7):683-7. PubMed ID: 4118600
[No Abstract] [Full Text] [Related]
17. [Practical problems to be faced in anti-aggregation and anticoagulant therapy].
Boneu B
Rev Prat; 1978 Jun; 28(35):2747-60. PubMed ID: 79213
[No Abstract] [Full Text] [Related]
18. Case Report of Severe Antithrombin Deficiency During Extracorporeal Membrane Oxygenation and Therapeutic Plasma Exchange for Double Lung Transplantation.
Williams B; Mazzeffi MA; Sanchez PG; Pham SM; Kon Z; Tanaka KA
A A Case Rep; 2017 Jan; 8(1):11-13. PubMed ID: 28036320
[TBL] [Abstract][Full Text] [Related]
19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
20. Hereditary antithrombin III deficiency and venous thrombosis.
Michiels JJ; Van Vliet HH
Neth J Med; 1984; 27(6):226-32. PubMed ID: 6379481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
